ADMA
ADMA Biologics, Inc. · Healthcare · Biotechnology
Momentum inputs (comparable managers):
holder breadth -15.4% ·
share flow -0.5% ·
net new positions -18.2%
— formula
Broad distribution — falling shares and fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 107 | -1 | 146.21M | $1.22B | +9 | −10 |
| Q1 2026 | 111 | -5 | 163.83M | $1.48B | +7 | −12 |
| Q4 2025 | 115 | +1 | 163.64M | $2.98B | +1 | — |
| Q3 2025 | 19 | +1 | 92.34M | $1.35B | +3 | −3 |
| Q2 2025 | 16 | -1 | 89.41M | $1.63B | +1 | −2 |
| Q1 2025 | 14 | 0 | 31.71M | $629.12M | — | — |
| Q4 2024 | 14 | +2 | 37.00M | $634.64M | +2 | — |
| Q3 2024 | 11 | -2 | 23.86M | $476.89M | — | −2 |
| Q2 2024 | 13 | — | 23.97M | $268.00M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (passive) | 5.38M | +2.6% | $107.61M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 5.38M | +2.6% | $107.61M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | D. E. Shaw & Co. ✦ | 5.26M | -22.9% | $105.23M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 4 | D. E. Shaw & Co. ✦ | 5.26M | -22.9% | $105.23M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 5 | Renaissance Technologies ✦ | 3.67M | +42.0% | $73.31M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 6 | Two Sigma Investments ✦ | 3.59M | -10.8% | $71.79M | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 7 | T. Rowe Price ✦ | 2.10M | +1.1% | $41.98M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | T. Rowe Price ✦ | 2.10M | +1.1% | $41.98M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | Arrowstreet Capital ✦ | 1.75M | +163.0% | $34.97M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | Millennium Management ✦ | 1.12M | +18.7% | $22.33M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | AQR Capital Management ✦ | 589.31K | -23.8% | $11.78M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 589.31K | -23.8% | $11.78M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 589.31K | -23.8% | $11.78M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 14 | Gotham Asset Management ✦ | 164.56K | +110.6% | $3.29M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 15 | Wellington Management ✦ | 119.29K | -80.1% | $2.38M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 16 | Wellington Management ✦ | 119.29K | -80.1% | $2.38M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 17 | Wellington Management ✦ | 119.29K | -80.1% | $2.38M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 18 | Wellington Management ✦ | 119.29K | -80.1% | $2.38M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 19 | Point72 Asset Management ✦ | 111.01K | +7.3% | $2.22M | 0.0% | ▲ Add | 2 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| Citadel Advisors | $339,324 | was 0.0% |
| Marshall Wace | $299,624 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 355 holders, 211.31M shares, $1.84B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.